Testing of newly modified Korean anticancer drug approved by U.S. FDA

Published: 2009-08-14 06:59:00

Updated: 2009-08-14 06:59:00

SK Chemicals Co., Ltd. said on August 11 it has received approval from the U.S. Food and Drug Administration to conduct advanced clinical trial of a drug for the treatment of cancer.

During the year 2008, the company developed newly modified anticancer drug 'SID530' (docetaxel) by its Life Sci...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK